{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:50:09Z","timestamp":1791352209128,"version":"4.3.1"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mixed-grade glioma surgical cohorts exhibit highly variable low-grade glioma (LGG) proportions across studies. This meta-analysis quantifies pooled LGG proportions to provide cohort-level epidemiological benchmarks for researchers, with applications in clinical trial design, health economics, and institutional benchmarking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A single-arm meta-analysis of 191 cohort studies (25,847 patients) with Grade II numerators and denominators from Embase, MEDLINE, PubMed, and Scopus (PRISMA 2020) used Freeman-Tukey random-effects synthesis with Cochrane risk-of-bias assessments; subgroup analyses examined study design, geography, era, molecular specificity, and interventions; sensitivity analyses tested robustness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The pooled LGG proportion was 57% (95% CI: 52%-61%; I\u00b2=99%; n=191). Mixed LGG\/high-grade gliomas (HGG) cohorts showed 41% (32%-50%; 45 studies, 6,847 patients) versus 82% (77%-88%) in pure WHO Grade II cohorts (25 studies). Surgery-only cohorts demonstrated 46% (33%-59%) versus 86% (74%-98%) with targeted therapies, and 93% (90%-96%) in randomized controlled trials. Sensitivity analyses confirmed stability (50%-62%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In mixed-grade glioma cohorts, an LGG proportion approaching 60% may serve as a cohort-level epidemiological reference for understanding the historical grade composition of mixed surgical series. This meta-analysis primary value lies in applications such as clinical trial design, health economics and epidemiological modeling, and institutional benchmarking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero\/<\/jats:ext-link>\n                      , identifier CRD420261323907.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1888445","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:53:05Z","timestamp":1791348785000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Cohort-level proportions of low-grade glioma (WHO grades I\u2013II) in mixed glioma cohorts: a single-arm meta-analysis for epidemiological benchmarking and clinical trial design"],"prefix":"10.3389","volume":"16","author":[{"given":"Shenao","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Radiology, The Second Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Second Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinjiao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Second Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Second Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjun","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Second Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Second Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihong","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Second Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Second Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-025-05279-4","article-title":"Low tumour burden is associated with observation after surgery in patients with grade 2 astrocytoma and oligodendroglioma: results from the prospective multicentre LoG-Glio registry","volume":"176","author":"Ziebart","year":"2026","journal-title":"J Neuro-Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2026.01.27.26344883","DOI":"10.64898\/2026.01.27.26344883","article-title":"External validation of self-supervised transfer learning for noninvasive molecular subtyping of pediatric low-grade glioma using T2-weighted MRI","author":"Yoo","year":"2026","journal-title":"medRxiv"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(25)00534-0","article-title":"A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group","volume":"26","author":"Karschnia","year":"2025","journal-title":"Lancet Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-025-05269-6","article-title":"Prospective phase II clinical trial of molecular glioblastoma (historical grade 2 and 3 IDH wildtype gliomas) preliminary novel exploratory analyses","volume":"176","author":"Yeboa","year":"2026","journal-title":"J Neuro-Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11060-025-05299-0","article-title":"Clinical predictors of pseudoprogression in glioblastoma: a retrospective cohort analysis","volume":"176","author":"Hoosemans","year":"2026","journal-title":"J Neuro-Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/neuonc\/noae164","article-title":"Contemporary prognostic signatures and refined risk stratification of gliomas: an analysis of 4400 tumors","volume":"27","author":"Ghosh","year":"2025","journal-title":"Neuro-oncology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(25)00472-3","article-title":"Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"26","author":"Cloughesy","year":"2025","journal-title":"Lancet Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"112513","DOI":"10.1016\/j.jpsychores.2025.112513","article-title":"Cross-sectional survey: Characteristics and associated factors of cancer-related fatigue in patients after glioma surgery","volume":"203","author":"Han","year":"2026","journal-title":"J Psychosomatic Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-025-05338-w","article-title":"Return to intensive sport activities following awake functional-guided surgical resection of IDH-mutated low-grade glioma","volume":"176","author":"Duffau","year":"2026","journal-title":"J Neuro-Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s11060-026-05522-6","article-title":"Pubertal development and hormonal modulation in pediatric low-grade gliomas: A retrospective cohort study","volume":"177","author":"D'Antonio","year":"2026"},{"key":"B11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s12149-025-02138-0","article-title":"Complementary prognostic value of hotspot-to-centroid distance (NHOCpeak) to SUVpeak in high-grade glioma","volume":"40","author":"Bosque","year":"2026","journal-title":"Ann Nucl Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noad160","article-title":"Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect group","volume":"26","author":"Karschnia","year":"2024","journal-title":"Neuro-oncology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/jco.23.01838","article-title":"Everolimus for children with recurrent or progressive low-grade glioma: results from the phase II PNOC001 trial","volume":"42","author":"Haas-Kogan","year":"2024","journal-title":"J Clin Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12883-020-01888-w","article-title":"Establishment of age group classification for risk stratification in glioma patients","volume":"20","author":"Lin","year":"2020","journal-title":"BMC Neurol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-024-04737-9","article-title":"Comparative analysis of molecular and histological glioblastomas: insights into prognostic variance","volume":"169","author":"Lee","year":"2024","journal-title":"J Neuro-Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13060","article-title":"The 2021 WHO classification of tumors of the central nervous system: an update on pediatric low\u2010grade gliomas and glioneuronal tumors","volume":"32","author":"Bale","year":"2022","journal-title":"Brain Pathol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10555-021-09997-9","article-title":"Glioma: molecular signature and crossroads with tumor microenvironment","volume":"41","author":"Barthel","year":"2022","journal-title":"Cancer Metastasis Rev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-1180","article-title":"Tumor volume growth rates and doubling times during active surveillance of IDH-mutant low-grade glioma","volume":"30","author":"Bhatia","year":"2024","journal-title":"Clin Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41698-023-00448-y","article-title":"First-in-human prospective trial of sonobiopsy in high-grade glioma patients using neuronavigation-guided focused ultrasound","volume":"7","author":"Yuan","year":"2023","journal-title":"NPJ Precis Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.a7916","article-title":"T2-FLAIR mismatch sign in pediatric low-grade glioma","volume":"44","author":"Wagner","year":"2023","journal-title":"Am J Neuroradiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noad078","article-title":"LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patients","volume":"25","author":"Hardin","year":"2023","journal-title":"Neuro-oncology"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1888445\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:53:06Z","timestamp":1791348786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1888445\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":21,"alternative-id":["10.3389\/fonc.2026.1888445"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1888445","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"article-number":"1888445"}}